Tumor anorexia: effects on neuropeptide Y and monoamines in paraventricular nucleus

[1]  C. Dourish,et al.  Role of dopamine D-1 and D-2 receptor subtypes in mediating dopamine agonist effects on food consumption in rats , 1988, Psychopharmacology.

[2]  J. Knoll,et al.  An HPLC tracing of the enhancer regulation in selected discrete brain areas of food-deprived rats. , 2003, Life sciences.

[3]  R. Cone,et al.  Differential role of melanocortin receptor subtypes in cachexia. , 2003, Endocrinology.

[4]  L. Gatto,et al.  Decreased NPY innervation of the hypothalamic nuclei in rats with cancer anorexia , 2003, Brain Research.

[5]  M. Meguid,et al.  Distribution of serotonin 5-hydroxytriptamine 1B (5-HT1B) receptors in the normal rat hypothalamus , 2002, Neuroscience Letters.

[6]  M. Low,et al.  Activation of Central Melanocortin Pathways by Fenfluramine , 2002, Science.

[7]  A. Lira,et al.  Hypothalamic paraventricular 5-hydroxytryptamine: Receptor-specific inhibition of NPY-stimulated eating and energy metabolism , 2002, Pharmacology Biochemistry and Behavior.

[8]  D. Kuo.  Co-administration of dopamine D1 and D2 agonists additively decreases daily food intake, body weight and hypothalamic neuropeptide Y level in rats. , 2002, Journal of biomedical science.

[9]  L. Zhang,et al.  Hypothalamic dopaminergic receptor expressions in anorexia of tumor-bearing rats. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[10]  S. Fetissov,et al.  Synchronized release of dopamine and serotonin in the medial and lateral hypothalamus of rats , 2000, Neuroscience.

[11]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[12]  A. Cincotta,et al.  Dopaminergic Agonists Normalize Elevated Hypothalamic Neuropeptide Y and Corticotropin-Releasing Hormone, Body Weight Gain, and Hyperglycemia in ob/ob Mice , 2000, Neuroendocrinology.

[13]  Z. Zadák,et al.  Interleukin-1α Injection Into Ventromedial Hypothalamic Nucleus of Normal Rats Depresses Food Intake and Increases Release of Dopamine and Serotonin , 1999, Pharmacology Biochemistry and Behavior.

[14]  A. Laviano,et al.  Food Intake Equals Meal Size Times Mean Number , 1998, Appetite.

[15]  S. MohanKumar,et al.  Specificity of interleukin–1β-induced changes in monoamine concentrations in hypothalamic nuclei: blockade by interleukin-1 receptor antagonist1 1 Dedicated to the memory of Dr. S. K. Quadri, a distinguished scientist and an inspiring teacher. , 1998, Brain Research Bulletin.

[16]  Y. Michotte,et al.  Dopaminergic regulation of serotonin release in the substantia nigra of the freely moving rat using microdialysis , 1998, Brain Research.

[17]  Z. Zadák,et al.  Ventromedial nucleus of hypothalamus is related to the development of cancer-induced anorexia: in vivo microdialysis study. , 1998, Acta medica.

[18]  A. Laviano,et al.  Meal size and number: relationship to dopamine levels in the ventromedial hypothalamic nucleus. , 1997, The American journal of physiology.

[19]  E. Gibson,et al.  Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. , 1997, TIPS - Trends in Pharmacological Sciences.

[20]  F. Rossi Fanelli,et al.  Cracking the riddle of cancer anorexia. , 1996, Nutrition.

[21]  M. Meile,et al.  Hypothalamic monoamines and insulin in relation to feeding in the genetically obese Zucker rat as revealed by microdialysis. , 1995, Obesity research.

[22]  S. Dryden,et al.  The serotonin (5-HT) antagonist methysergide increases neuropeptide Y (NPY) synthesis and secretion in the hypothalamus of the rat , 1995, Brain Research.

[23]  S. Dryden,et al.  Neuropeptide Y and energy balance: one way ahead for the treatment of obesity? , 1994, European journal of clinical investigation.

[24]  J. Fischer,et al.  Possible role of neuropeptide Y in experimental cancer anorexia. , 1994, Advances in experimental medicine and biology.

[25]  P. MohanKumar,et al.  Interleukin-1β increases 5-hydroxyindoleacetic acid release in the hypothalamus in vivo , 1993, Brain Research Bulletin.

[26]  B. Stanley,et al.  Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake , 1993, Brain Research.

[27]  H. McCarthy,et al.  Alterations in hypothalamic NPY and CRF in anorexic tumor-bearing rats. , 1993, The American journal of physiology.

[28]  S. Leibowitz,et al.  The perifornical area: the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system(s) , 1993, Brain Research.

[29]  Gareth H. Williams,et al.  Acute fenfluramine administration reduces neuropeptide Y concentrations in specific hypothalamic regions of the rat: Possible implications for the anorectic effect of fenfluramine , 1991, Peptides.

[30]  W. J. Mueller,et al.  Automated computerized rat eater meter: Description and application , 1990, Physiology & Behavior.

[31]  B. Hoebel,et al.  Microdialysis Studies of Brain Norepinephrine, Serotonin, and Dopamine Release During Ingestive Behavior Theoretical and Clinical Implications a , 1989, Annals of the New York Academy of Sciences.

[32]  G. Pelletier,et al.  The role of dopamine in the control of neuropeptide Y neurons in the rat arcuate nucleus , 1986, Neuroscience Letters.

[33]  J. Palacios,et al.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.

[34]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[35]  M. Palkovits,et al.  Isolated removal of hypothalamic or other brain nuclei of the rat. , 1973, Brain research.